New Drugs of 2012, Part 1

Michael A. Mancano, PharmD
Published Online: Tuesday, February 19, 2013
Follow Pharmacy_Times:

New Drugs of 2012, Part 1

Michael A. Mancano, PharmD
Clinical Professor of Pharmacy Practice
Chair, Department of Pharmacy Practice
Temple University School of Pharmacy
Philadelphia, Pennsylvania

Clinical Consultant, Pennsylvania Hospital
Department of Pharmacy
Philadelphia, Pennsylvania


The following contributors have no relevant financial relationships with commercial interests to disclose.

Michael A. Mancano, PharmD

Pharmacy Times Office of Continuing Professional Education Planning Staff
Judy V. Lum, MPA, and Elena Beyzarov, PharmD

Pharmacy Times Editorial Staff
Jennifer Whartenby and David Allikas

PTOCPE uses an anonymous peer reviewer as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  1. Discuss the clinical indications of the new drugs approved by the FDA in 2012.
  2. Explain the various mechanisms of action of the drugs discussed within this activity.
  3. Identify the clinically relevant drug interactions and the most common adverse reactions for the drugs reviewed in this activity.
  4. Explain the approved dosing guidelines and recommended dosage adjustments for the drugs reviewed.

Target audience: Pharmacists
Type of activity: Knowledge
Release date: February 10, 2013
Expiration date: February 10, 2015
Estimated time to complete activity: 2 hours
Fee: This lesson is free online

Click here to view this activity.

Related Articles
After completing this continuing education program, participants should be able to assess the clinical indications for new drugs approved by the FDA in 2014.
The Accreditation Council for Pharmacy Education is pleased to announce the release of two key documents that provide the profession with guidance and support for continuing pharmacy education and continuing professional development.
The American Pharmacists Association is pleased to announce that the association’s education team and The Pharmacist & Patient-Centered Diabetes Care Certificate Training Program were honored with the 2015 Award for Outstanding Live CE Activity by the Alliance for Continuing Education in the Health Professions.
Senators John McCain and Amy Klobuchar have reintroduced the Safe and Affordable Drugs from Canada Act, which would allow individuals to import prescription drugs from Canada.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times